JP Morgan Chase’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$108 7639
2025
Q1
$108 Buy
+100
New +$98 ﹤0.01% 6866
2022
Q2
Sell
-86,258
Closed -$91K 6888
2022
Q1
$91K Buy
+86,258
New +$76.4K ﹤0.01% 5552

Other funds holding TLSA

JP Morgan Chase's TLSA Position: Q2 2025 in Review

JP Morgan Chase sold out of Tiziana Life Sciences (TLSA) in Q2 2025, closing a stake of 100 shares — an estimated $108 sold.

JP Morgan Chase first reported a position in TLSA in Q1 2022 and held it in 2 quarters. The position peaked at $91K in Q1 2022. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2025.

  • JP Morgan Chase reported no remaining Tiziana Life Sciences position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 100 Tiziana Life Sciences shares in Q2 2025, an estimated $108.
  • JP Morgan Chase first reported a position in Tiziana Life Sciences in Q1 2022 and held it in 2 quarters.
  • JP Morgan Chase's Tiziana Life Sciences position peaked at $91K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.